CervoMed Inc. (CRVO)
NASDAQ: CRVO · Real-Time Price · USD
4.020
+0.010 (0.25%)
At close: Mar 4, 2026, 4:00 PM EST
4.150
+0.130 (3.23%)
Pre-market: Mar 5, 2026, 8:05 AM EST
CervoMed Market Cap
CervoMed has a market cap or net worth of $37.2 million as of March 5, 2026. Its market cap has increased by 102.09% in one year.
Market Cap
37.20M
Enterprise Value
9.90M
1-Year Change
102.09%
Ranking
Category
Stock Price
$4.02
Market Cap Chart
Since August 17, 2023, CervoMed's market cap has decreased from $43.26M to $37.20M, a decrease of -14.02%. That is a compound annual growth rate of -5.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 37.20M | -49.11% |
| Dec 31, 2025 | 73.10M | 278.47% |
| Dec 31, 2024 | 19.31M | -55.39% |
| Dec 29, 2023 | 43.30M | 0.08% |
| Aug 17, 2023 | 43.26M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Actinium Pharmaceuticals | 38.37M |
| PDS Biotechnology | 38.30M |
| NovaBay Pharmaceuticals | 38.14M |
| Lisata Therapeutics | 38.02M |
| Tvardi Therapeutics | 37.71M |
| Tevogen Bio Holdings | 37.52M |
| AN2 Therapeutics | 36.72M |
| Outlook Therapeutics | 36.42M |